GLP-1 Weight-Loss Drugs (Ozempic, Wegovy, Mounjaro)?

→ Closing the Information Gap in Health Care by Empowering Doctors and Patients through Online Feedback

GLP-1 weight-loss medications—including Ozempic, Wegovy, and Mounjaro—are rapidly transforming obesity and metabolic care. Clinical trials show strong results, but real-world experiences vary widely in effectiveness, side-effect severity, long-term sustainability, cost, and quality-of-life impact.

This PByT Hub captures the six most important questions that matter in assessing GLP-1 outcomes. Each question can be answered by both users and medical professionals, giving a global picture of real-world results.

Statement:

Based on my experience (or my patients’ experience), GLP-1 drugs have been effective for weight loss and appropriately safe. (AGREE / DISAGREE)

___

Additional Key Questions/Issues

How Severe Are GLP-1 Side Effects?

Overall Satisfaction With GLP-1 Treatment?

Concern About Long-Term Use of GLP-1 Drugs?

Would You Choose GLP-1 Again?

Has GLP-1 Improved Overall Quality of Life?

***

About PByT Surveys & Open Democracy

The PByT surveys represent a rolling snapshot of global sentiment from real people whose identity has been verified. The results can be analyzed in a variety of ways to get a better understanding of key issues utilizing Bayesian statistics - a mathematical concept that updates beliefs in light of new data or evidence.

As a result, these surveys have the potential to be the most definitive resources on some of the most critically important issues of modern times and serve as the basis for the idea of "open democracy."

Have your say and help shape the interconnected world of tomorrow based on trust, mutual-aid and cooperation.